Drugmaker Seeks to Block Nebraska from Using Execution Drugs

A German pharmaceutical company has filed a lawsuit to prevent Nebraska from using lethal injection drugs next week in what would be the state’s first execution in more than two decades. The federal lawsuit could delay the Aug. 14 execution of Carey Dean Moore, who was sentenced to death for killing two cab drivers in 1979.

The company, Fresenius Kabi, opposes the use of its drugs in executions and alleges that the Nebraska Department of Corrections’ supply of potassium chloride was made through improper or illegal means. This is not the first time that Nebraska has had a run-in with Fresenius Kabi; last year state officials received a batch of potassium chloride because of a distribution error. Nebraska has never carried out an execution by lethal injection, and the state plans to use an untried combination of drugs for Moore’s execution.